Elevated expression of CMTM6 has been associated with poor prognosis, including reduced survival rates and increased risk of tumor recurrence in several cancer types, such as lung cancer, melanoma, and colorectal cancer (58–60). This evidence concerns the gene CMTM6 and melanoma.